Interventional stroke therapy: Current state of the art and needs assessment

Catheterization and Cardiovascular Interventions

Volumn 70, Issue 3, 2007, Pages 471-476

  White, Christopher J ^a   Cates, Christopher U ^b   Cowley, Michael J ^c   Weiner, Bonnie H ^d   Carpenter, Jeffrey S ^e   Hopkins, L Nelson ^f   Jaff, Michael R ^g   Ramee, Stephen R ^a   Rymer, Marilyn M ^h   Wholey, Mark H ⁱ  

^a OCHSNER CLINIC FOUNDATION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SAINT VINCENT HOSPITAL   (United States)

^e WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h ST LUKE S HOSPITAL   (United States)

ⁱ UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Peripheral vascular disease (PVD); Stroke; Thrombolytic

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; RECOMBINANT PLASMINOGEN ACTIVATOR;

BRAIN ANGIOGRAPHY; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HEART INFARCTION; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE; PERFUSION WEIGHTED IMAGING; REPERFUSION; REVIEW; STENT; CRYOANESTHESIA; EDITORIAL; FIBRINOLYTIC THERAPY; METHODOLOGY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; STANDARD;

CEREBROVASCULAR ACCIDENT; HUMANS; HYPOTHERMIA, INDUCED; OUTCOME ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES; THROMBOLYTIC THERAPY;

EID: 35848947223     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21336     Document Type: Review

References (30)

1. Rosamond W, et al. Heart disease and stroke statistics - 2007 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007;115:e69-e171.
2. Sacco RL, et al. American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke 1997;28:1507-1517.
3. Marder VJ, et al. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086-2093.
4. Adams HP Jr, et al. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurol ogy affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-e534.
5. Smith WS, et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005;36:1432-1438.
6. 2005 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation 2005; 112(24 Suppl):IV1-IV203.
7. Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 2005;36:2500-2503.
8. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581-1587.
9. Albers GW, et al. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The Standard Treatment with Alteplase to Reverse Stroke (STARS) study. JAMA 2000;283:1145-1150.
10. Reed SD, et al. Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001;32:1832-1840.
11. Moodie ML, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 2004;35:1041-1046.
12. Clark WM, et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. JAMA 1999;282:2019-2026.
13. California Acute Stroke Pilot Registry Investigators. Prioritizing interventions to improve rates of thrombolysis for ischemic stroke. Neurology 2005;64:654-659.
14. Lopez-Yunez AM, et al. Protocol violations in community-based rTPA stroke treatment are associated with symptomatic intracerebral hemorrhage. Stroke 2001;32:12-16.
15. Buchan AM, et al. Effectiveness of t-PA in acute ischemic stroke: Outcome relates to appropriateness. Neurology 2000;54:679-684.
16. Tanne D, et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. The t-PA Stroke Survey Group. Neurology 1999;53:424-427.
17. Furlan A, et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282: 2003-2011.
18. Smith WS. Safety of mechanical thrombectomy and intravenous tissue plasminogen activator in acute ischemic stroke. Results of the multi Mechanical Embolus Removal in Cerebral Ischemia (MERCI) trial, Part I. AJNR Am J Neuroradiol 2006;27:1177-1182.
19. Flint AC, et al. Mechanical thrombectomy of intracranial internal carotid occlusion: Pooled results of the MERCI and Multi MERCI Part I trials. Stroke 2007;38:1274-1280.
20. Alberts MJ, et al. Recommendations for the Establishment of Primary Stroke Centers. JAMA 2000;283:3102-3109.
21. Alberts MJ, et al. Recommendations for Comprehensive Stroke Centers: A consensus statement from the brain attack coalition. Stroke 2005;36:1597-1616.
22. Wojner-Alexandrov AW, et al. Houston paramedic and emergency stroke treatment and outcomes study (HoPSTO). Stroke 2005;36:1512-1518.
23. Gropen TI, et al. Quality improvement in acute stroke: The New York State Stroke Center Designation Project. Neurology 2006; 67:88-93.
24. Rymer MM, Thrutchley DE. Organizing regional networks to increase acute stroke intervention. Neurol Res 2005;27(Suppl. 1): S9-S16.
25. Ramee SR, et al. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109-e111.
26. Frey JL, et al. tPA by telephone: Extending the benefits of a comprehensive stroke center. Neurology 2005;64:154-156.
27. Suzuki S, et al. Access to intra-arterial therapies for acute ischemic stroke: An analysis of the US population. AJNR Am J Neuroradiol 2004;25:1802-1806.
28. Wholey MH, et al. Current global status of carotid artery stent placement. Catheter Cardiovasc Diagn 1998;44:1-6.
29. Wholey MH, et al. Global experience in cervical carotid artery stent placement. Catheter Cardiovasc Interv 2000;50:160-167.
30. Wholey M, Al-Mubarek N, Wholey M. Updated review of the global carotid artery stent registry. Catheter Cardiovasc Interv 2003;60:259-266.